We are pleased to announce that Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions from 5th to 8th September in Chicago, Illinois.

This event, hosted by the American Heart Association, brings together leading experts to discuss the latest research and advancements in hypertension.

The conference features oral and poster presentations, panel discussions, and sessions tailored for clinicians, researchers, and primary care providers.

To connect with Dr. Taubel during the event, please reach out to arrange a meeting.

Tofind out more, click here.

Latest news

Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director

August 1, 2025
Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025.
Read more

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Events

JSCPT 2025

5th –6th December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event